Neil Venardos1, Daine Bennett2, Michael J Weyant2, Thomas Brett Reece2, Xianzhong Meng2, David A Fullerton2. 1. Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Aurora, Colorado. Electronic address: Neil.Venardos@ucdenver.edu. 2. Department of Surgery, Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Aurora, Colorado.
Abstract
BACKGROUND: The aortic valve interstitial cell (AVIC) has been implicated in the pathogenesis of aortic stenosis. In response to proinflammatory stimulation, the AVIC undergoes a phenotypic change from that of a myofibroblast phenotype to that of osteoblast-like cell. Matrix Gla-protein (MGP) has been identified as an important inhibitor of vascular calcification. We therefore hypothesized that MGP expression is reduced in diseased AVICs, and loss of this protective protein contributes to calcification of the aortic valve. Our purpose was to compare MGP expression in normal versus diseased AVICs. MATERIALS AND METHODS: Human AVICs were isolated from normal aortic valves from explanted hearts (n = 6) at the time of heart transplantation. AVICs were also isolated from calcified, diseased valves of patients (n = 6) undergoing aortic valve replacement. AVICs were grown in culture until they reached passages 2-6 before experimentation. Immunofluorescent staining, reverse transcriptase-polymerase chain reaction, immunoblotting, and enzyme-linked immunosorbent assay were used to compare levels of MGP in normal and diseased AVICs. Statistics were performed using the Mann-Whitney U test (P < 0.05). RESULTS: MGP expression was significantly decreased in diseased AVICs relative to normal AVICs by immunofluorescent staining, reverse transcriptase-polymerase chain reaction, immunoblotting, and enzyme-linked immunosorbent assay. CONCLUSIONS: An important anti-calcification defense mechanism is deficient in calcified aortic valves. MGP expression is significantly lower in diseased relative to normal AVICs. Lack of this important "anti-calcification" protein may contribute to calcification of the aortic valve.
BACKGROUND: The aortic valve interstitial cell (AVIC) has been implicated in the pathogenesis of aortic stenosis. In response to proinflammatory stimulation, the AVIC undergoes a phenotypic change from that of a myofibroblast phenotype to that of osteoblast-like cell. Matrix Gla-protein (MGP) has been identified as an important inhibitor of vascular calcification. We therefore hypothesized that MGP expression is reduced in diseased AVICs, and loss of this protective protein contributes to calcification of the aortic valve. Our purpose was to compare MGP expression in normal versus diseased AVICs. MATERIALS AND METHODS:Human AVICs were isolated from normal aortic valves from explanted hearts (n = 6) at the time of heart transplantation. AVICs were also isolated from calcified, diseased valves of patients (n = 6) undergoing aortic valve replacement. AVICs were grown in culture until they reached passages 2-6 before experimentation. Immunofluorescent staining, reverse transcriptase-polymerase chain reaction, immunoblotting, and enzyme-linked immunosorbent assay were used to compare levels of MGP in normal and diseased AVICs. Statistics were performed using the Mann-Whitney U test (P < 0.05). RESULTS:MGP expression was significantly decreased in diseased AVICs relative to normal AVICs by immunofluorescent staining, reverse transcriptase-polymerase chain reaction, immunoblotting, and enzyme-linked immunosorbent assay. CONCLUSIONS: An important anti-calcification defense mechanism is deficient in calcified aortic valves. MGP expression is significantly lower in diseased relative to normal AVICs. Lack of this important "anti-calcification" protein may contribute to calcification of the aortic valve.
Authors: T Ueland; L Gullestad; C P Dahl; P Aukrust; S Aakhus; O G Solberg; C Vermeer; L J Schurgers Journal: J Intern Med Date: 2010-11 Impact factor: 8.989
Authors: Ralf Koos; Thilo Krueger; Ralf Westenfeld; Harald Peter Kühl; Vincent Brandenburg; Andreas Horst Mahnken; Sven Stanzel; Cees Vermeer; Ellen C M Cranenburg; Jürgen Floege; Malte Kelm; Leon J Schurgers Journal: Thromb Haemost Date: 2009-04 Impact factor: 5.249
Authors: Romain Capoulade; Nancy Côté; Patrick Mathieu; Kwan L Chan; Marie-Annick Clavel; Jean G Dumesnil; Koon K Teo; James W Tam; Dominique Fournier; Jean-Pierre Després; Philippe Pibarot Journal: Can J Cardiol Date: 2014-03-24 Impact factor: 5.223
Authors: Xianzhong Meng; Lihua Ao; Yong Song; Ashok Babu; Xiaoping Yang; Maorong Wang; Michael J Weyant; Charles A Dinarello; Joseph C Cleveland; David A Fullerton Journal: Am J Physiol Cell Physiol Date: 2007-10-17 Impact factor: 4.249
Authors: Frederique E C M Peeters; Manouk J W van Mourik; Steven J R Meex; Jan Bucerius; Simon M Schalla; Suzanne C Gerretsen; Casper Mihl; Marc R Dweck; Leon J Schurgers; Joachim E Wildberger; Harry J G M Crijns; Bas L J H Kietselaer Journal: Nutrients Date: 2018-03-21 Impact factor: 5.717
Authors: Hiu-Gwen Tsang; Emily L Clark; Greg R Markby; Stephen J Bush; David A Hume; Brendan M Corcoran; Vicky E MacRae; Kim M Summers Journal: Front Genet Date: 2020-09-08 Impact factor: 4.599
Authors: Alexandru Florea; M Eline Kooi; Werner Mess; Leon J Schurgers; Jan Bucerius; Felix M Mottaghy Journal: Nutrients Date: 2021-03-19 Impact factor: 6.706